Fidelity Investments Portfolio holdings
Fidelity Investments, founded in 1946 by Edward C. Johnson II and headquartered in Boston, Massachusetts, is one of the largest privately-held financial services firms in the world, managing hundreds of billions in assets. Known for its wide array of investment products, including mutual funds, retirement accounts, brokerage services, and wealth management, Fidelity caters to both individual investors and institutions with a reputation for strong customer service and innovative tools like its active trader platforms. The company pioneered direct-to-investor mutual fund sales, bypassing traditional brokers, and has since expanded into areas like cryptocurrency trading and commission-free stock trades. Still family-controlled by the Johnson family, Fidelity blends a legacy of traditional investing with a forward-looking approach to technology and market trends.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$1.51B |
| 2 |
Microsoft
MSFT
|
+$1.13B |
| 3 |
Alphabet (Google) Class A
GOOGL
|
+$1.04B |
| 4 |
American Express
AXP
|
+$714M |
| 5 |
HCA Healthcare
HCA
|
+$675M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Amgen
AMGN
|
+$6.87B |
| 2 |
Wells Fargo
WFC
|
+$6.1B |
| 3 |
Becton Dickinson
BDX
|
+$3.96B |
| 4 |
Tesla
TSLA
|
+$3.74B |
| 5 |
3M
MMM
|
+$1.33B |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 19.87% |
| 2 | Financials | 15.4% |
| 3 | Healthcare | 15.27% |
| 4 | Consumer Discretionary | 11.41% |
| 5 | Communication Services | 10.62% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
ALBO
1751
DELISTED
Albireo Pharma Inc
ALBO
| $15.9M | ﹤0.01% |
481,000
-146,732
| -23% | -$4.8M |
|
1752
Ocular Therapeutix
OCUL
$2.02B
| $15.8M | ﹤0.01% |
2,300,399
-939,049
| -29% | -$5.89M |
|
|
WBT
1753
DELISTED
Welbilt, Inc.
WBT
| $15.8M | ﹤0.01% |
+757,964
| New | +$16.7M |
|
1754
LiveOne
LVO
$58.2M
| $15.8M | ﹤0.01% |
402,000
| – | – |
|
1755
Rithm Capital
RITM
$5.69B
| $15.8M | ﹤0.01% |
884,123
-80,755
| -8% | -$1.47M |
|
|
ESL
1756
DELISTED
Esterline Technologies
ESL
| $15.7M | ﹤0.01% |
172,843
+157,472
| +1,024% | +$13.2M |
|
1757
Pilgrim's Pride
PPC
$6.54B
| $15.6M | ﹤0.01% |
864,080
+200,837
| +30% | +$3.71M |
|
1758
Factset
FDS
$10.2B
| $15.4M | ﹤0.01% |
68,999
+1,329
| +2% | +$288K |
|
1759
Vornado Realty Trust
VNO
$7.38B
| $15.4M | ﹤0.01% |
211,099
+92,640
| +78% | +$6.87M |
|
1760
Trustmark
TRMK
$2.75B
| $15.4M | ﹤0.01% |
+457,095
| New | +$15.9M |
|
1761
MakeMyTrip
MMYT
$5.64B
| $15.4M | ﹤0.01% |
559,852
+19,087
| +4% | +$609K |
|
1762
Establishment Labs
ESTA
$2.28B
| $15.4M | ﹤0.01% |
+637,279
| New | +$16.4M |
|
|
CATM
1763
DELISTED
Cardtronics plc Class A Ordinary Shares (UK)
CATM
| $15.4M | ﹤0.01% |
485,284
+129,354
| +36% | +$3.98M |
|
|
EB
1764
DELISTED
Eventbrite
EB
| $15.3M | ﹤0.01% |
+404,000
| New | +$14.6M |
|
|
SVC
1765
Service Properties Trust
SVC
$1.07B
| $15.3M | ﹤0.01% |
106,332
+94,872
| +828% | +$13.6M |
|
1766
Intrepid Potash
IPI
$469M
| $15.2M | ﹤0.01% |
423,881
-1,681
| -0.4% | -$61.5K |
|
|
TVRD
1767
Tvardi Therapeutics
TVRD
$23.4M
| $15.1M | ﹤0.01% |
17,501
-1,714
| -9% | -$1.24M |
|
1768
Logitech
LOGI
$15.2B
| $15.1M | ﹤0.01% |
337,597
-518,095
| -61% | -$24M |
|
|
WHLRD
1769
Wheeler Real Estate Investment Trust Series D Preferred Stock
WHLRD
| $15.1M | ﹤0.01% |
741,248
| – | – |
|
|
CMRX
1770
DELISTED
Chimerix, Inc.
CMRX
| $15.1M | ﹤0.01% |
3,872,430
-1,053,849
| -21% | -$4.49M |
|
1771
Solid Biosciences
SLDB
$900M
| $15M | ﹤0.01% |
21,200
+17,157
| +424% | +$10.8M |
|
1772
PIMCO Enhanced Low Duration Active Exchange-Traded Fund
LDUR
$1.37B
| $14.9M | ﹤0.01% |
149,760
| – | – |
|
|
TAST
1773
DELISTED
Carrols Restaurant Group, Inc.
TAST
| $14.8M | ﹤0.01% |
1,013,796
-22,300
| -2% | -$338K |
|
1774
Loews
L
$23.6B
| $14.7M | ﹤0.01% |
293,467
+11,715
| +4% | +$587K |
|
1775
Kinross Gold
KGC
$32.8B
| $14.7M | ﹤0.01% |
5,376,327
-373,631
| -6% | -$1.21M |
|
Similar funds
Fidelity Investments's Q3 2018 Portfolio in Review
As of Q3 2018, Fidelity Investments held 3,957 positions worth $889B, up 2.3% from $869B the previous quarter. Its ten largest holdings account for 22% of the portfolio.
Fidelity Investments withdrew a net $33.9B in Q3 2018, closing 54 positions and reducing 1,318 holdings. Its most notable exit was Williams Partners L.P., an estimated $511M position sold in full.
By sector, the portfolio is most concentrated in Technology at 20% of assets, up from 18% a quarter earlier, followed by Financials and Healthcare.
Against the trend, Fidelity Investments opened a new position in Rubius Therapeutics, Inc worth $141M.
- Fidelity Investments's largest Q3 2018 buy was Rubius Therapeutics, Inc: 6,226,764 shares worth $141M.
- Fidelity Investments added most to Apple in Q3 2018, an estimated $1.51B increase.
- Fidelity Investments's biggest Q3 2018 reduction was Amgen, cutting an estimated $6.87B.
- Fidelity Investments fully exited Williams Partners L.P. in Q3 2018, selling an estimated $511M.
- Fidelity Investments's ten largest holdings make up 22% of its $889B portfolio in Q3 2018.
- Fidelity Investments opened 1,284 new positions and closed 54 in Q3 2018.
- Fidelity Investments's portfolio value rose 2.3% quarter-over-quarter to $889B.
Based on Fidelity Investments's 13F filing for Q3 2018, filed 9 Nov 2018.